Healthcare, Pharma & Life Sciences Regulations & CDSCO Gazette Updates
Comprehensive regulatory intelligence on Indian pharmaceuticals, medical devices, AYUSH, clinical trials, and digital health.
Healthcare, Pharmaceuticals & Life Sciences Regulatory Landscape & Compliance Overview
Official IntelligencePolicyIndex indexes real-time gazette notifications, policy orders, tariff determinations, and compliance circulars issued across the Healthcare, Pharmaceuticals & Life Sciences sector. Regulatory intelligence is aggregated across central ministries, state regulatory commissions, and statutory authorities.
Statutory Directives
Official Extraordinary Gazettes, S.O. & G.S.R. orders, and executive notifications.
Compliance Mandates
Sector-specific regulatory obligations, licensing norms, and statutory filing guidelines.
Specialized Healthcare, Pharmaceuticals & Life Sciences Verticals
Looking for Weekly Policy & Regulatory Briefings?
Access curated sector roundups, executive summaries, and downloadable PDF intelligence reports.
Latest Healthcare, Pharmaceuticals & Life Sciences News & Analysis
Health Ministry Moves Four Neurological Drugs to Schedule H1 List
The Health Ministry has issued draft rules adding Flupentixol, Zopiclone, Gabapentin, and Carisoprodol to Schedule H1 of the Drugs Rules, 19...
Official Healthcare, Pharmaceuticals & Life Sciences Gazettes & Notifications
Frequently Asked Questions on Healthcare, Pharmaceuticals & Life Sciences Regulations
Who regulates drugs and medical devices in India?
The Central Drugs Standard Control Organization (CDSCO), headed by the DCGI under the Ministry of Health and Family Welfare, regulates drugs, cosmetics, and medical devices.